These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 22748752)

  • 1. Catatonia associated with pegylated interferon-α 2b and ribavirin for hepatitis C.
    Quinn D; Kuchler E; Deming P; Arora S
    Psychosomatics; 2012; 53(4):400-1. PubMed ID: 22748752
    [No Abstract]   [Full Text] [Related]  

  • 2. Erythema Annulare Centrifugum in the Era of Triple Therapy With Boceprevir Plus Pegylated Interferon α-2b and Ribavirin for Hepatitis C Virus Infection.
    di Meo N; Stinco G; Fadel M; Errichetti E; Trevisan G
    J Cutan Med Surg; 2015; 19(3):203-4. PubMed ID: 26060126
    [No Abstract]   [Full Text] [Related]  

  • 3. Occurrence of hepatocellular carcinoma 13 years after successful antiviral treatment for HCV infection.
    Puoti C; Lanzetta G; Scotti E
    J Gastrointestin Liver Dis; 2016 Sep; 25(3):408-9. PubMed ID: 27689211
    [No Abstract]   [Full Text] [Related]  

  • 4. Commentary: efficacy and safety of ribavirin plus pegylated interferon-alpha in geriatric patients with chronic hepatitis C - authors' reply.
    Hu CC; Chien RN
    Aliment Pharmacol Ther; 2013 Feb; 37(4):492. PubMed ID: 23336679
    [No Abstract]   [Full Text] [Related]  

  • 5. Severe renal impairment during triple therapy with telaprevir.
    Carrier P; Chambaraud T; Vong C; Guillaudeau A; Debette-Gratien M; Jacques J; Legros R; Sautereau D; Essig M; Loustaud-Ratti V
    Clin Res Hepatol Gastroenterol; 2014 Sep; 38(4):e69-71. PubMed ID: 24461554
    [No Abstract]   [Full Text] [Related]  

  • 6. Peginterferon-alpha(2b) and ribavirin.
    Ahn J; Flamm S
    Expert Rev Anti Infect Ther; 2004 Feb; 2(1):17-25. PubMed ID: 15482168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C treatment, HAART and side effects.
    TreatmentUpdate; 2001; 13(7):7-8. PubMed ID: 11794865
    [No Abstract]   [Full Text] [Related]  

  • 8. Tongue hyperpigmentation during hepatitis C treatment.
    Bachmeyer C; Pellen JC
    CMAJ; 2012 Sep; 184(13):1498. PubMed ID: 22451683
    [No Abstract]   [Full Text] [Related]  

  • 9. "Hepatitis C (HCV) treatment is not a "one size fits all".
    Bukeirat FA; Bukeirat MM
    W V Med J; 2012; 108(2):20, 22-4. PubMed ID: 22655431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Information for patients. Treatment of acute hepatitis C].
    Otón Nieto E
    Rev Esp Enferm Dig; 2011 Oct; 103(10):549. PubMed ID: 22054273
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of the Safety Profiles of Pegylated Interferon α-2a and α-2b Administered in Combination with Ribavirin for Chronic Hepatitis C Infection: A Real-World Retrospective Cohort Study.
    Ide K; Sato I; Imai T; Hawke P; Yamada H; Kawasaki Y; Masaki N
    Biol Pharm Bull; 2016 Dec; 39(12):2060-2065. PubMed ID: 27645378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Summaries for patients. Pegylated interferon with or without ribavirin for patients with hepatitis C receiving hemodialysis.
    Ann Intern Med; 2013 Dec; 159(11):I-14. PubMed ID: 24297207
    [No Abstract]   [Full Text] [Related]  

  • 13. Retinal vein thrombosis associated with peginterferon alpha 2b plus ribavirin in a chronic hepatitis C patient.
    Such Díaz A; Barrueco N; Esteban Alba C; Escobar Rodríguez I
    Farm Hosp; 2011; 35(2):93-4. PubMed ID: 20615736
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect and safety of the treatment of recurrent hepatitis C infection after orthotopic liver transplantation with pegylated interferon α2b and ribavirin.
    Perrakis A; Yedibela S; Schuhmann S; Croner R; Schellerer V; Demir R; Hohenberger W; Müller V
    Transplant Proc; 2011 Dec; 43(10):3824-8. PubMed ID: 22172854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutaneous sarcoidosis associated with pegylated interferon alfa and ribavirin therapy in a patient with chronic hepatitis C.
    Rogers CJ; Romagosa R; Vincek V
    J Am Acad Dermatol; 2004 Apr; 50(4):649-50. PubMed ID: 15034524
    [No Abstract]   [Full Text] [Related]  

  • 16. Lingual hyperpigmentation from pegylated interferon and ribavirin treatment of hepatitis C.
    Farshidi D; Chiu MW
    J Am Acad Dermatol; 2010 Jan; 62(1):164-165. PubMed ID: 20082904
    [No Abstract]   [Full Text] [Related]  

  • 17. Rash from hepatitis C treatment.
    Tang DM; Ward L
    Cleve Clin J Med; 2011 Jul; 78(7):472-4. PubMed ID: 21724930
    [No Abstract]   [Full Text] [Related]  

  • 18. Major depressive episode with psychotic features induced by pegylated interferon-alpha-2b and ribavirin treatment.
    Sockalingam S; Balderson K
    Int Clin Psychopharmacol; 2005 Sep; 20(5):289-90. PubMed ID: 16096520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pegylated interferon and ribavirin therapy for hepatitis C causing cataract.
    Ku JY; Sharma A
    Clin Exp Ophthalmol; 2009 Sep; 37(7):743-5. PubMed ID: 19788675
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pericardial effusion associated to interferon in an immunocompetent patient].
    Velasco J; Oriñuela I; Sanjuán AZ; Ortiz de Zárate Z
    Enferm Infecc Microbiol Clin; 2010 Dec; 28(10):749-50. PubMed ID: 20579776
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.